ResearcherWestern UniversityActive in the last 2 years
Ephraim Shin-Tian Tang
Matched on ORCID iD 0000-0002-2392-3380; OpenAlex author ID A5109555866. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
2018: 1 paper · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper
Papers 4
- Survival benefit of neoadjuvant FOLFIRINOX for patients with borderline resectable pancreatic cancer. Co-author DOI 10.14701/ahbps.23-107↗
- Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancer. Co-author DOI 10.1080/2162402x.2021.1900635↗
- Transcriptional and immunohistological assessment of immune infiltration in pancreatic cancer. Co-author DOI 10.1371/journal.pone.0238380↗
- Association of Immunologic Markers With Survival in Upfront Resectable Pancreatic Cancer. Co-author DOI 10.1001/jamasurg.2018.1757↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Michael James Gough · 3 shared papers, 2018–2021 · strength 0.28
- Paper Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-t… DOI 10.1080/2162402x.2021.1900635↗
- Paper Transcriptional and immunohistological assessment of immune infiltration in pancreatic cancer. DOI 10.1371/journal.pone.0238380↗
- Paper Association of Immunologic Markers With Survival in Upfront Resectable Pancreatic Cancer. DOI 10.1001/jamasurg.2018.1757↗
- Paul Hansen · 3 shared papers, 2018–2021 · strength 0.28
- Paper Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-t… DOI 10.1080/2162402x.2021.1900635↗
- Paper Transcriptional and immunohistological assessment of immune infiltration in pancreatic cancer. DOI 10.1371/journal.pone.0238380↗
- Paper Association of Immunologic Markers With Survival in Upfront Resectable Pancreatic Cancer. DOI 10.1001/jamasurg.2018.1757↗
- Daniel Adam Breadner · 1 shared paper, 2024 · strength 0.22
- Evelyn V. Waugh · 1 shared paper, 2024 · strength 0.22
- Anton I. Skaro · 1 shared paper, 2024 · strength 0.22
- Juan Glinka · 1 shared paper, 2024 · strength 0.22
- Ken A. Leslie · 1 shared paper, 2024 · strength 0.22
- Marka R. Crittenden · 2 shared papers, 2020–2021 · strength 0.19
- Terry R. Medler · 2 shared papers, 2020–2021 · strength 0.19
- Kristina Hoot Young · 2 shared papers, 2020–2021 · strength 0.19
- Brady M. Bernard · 2 shared papers, 2020–2021 · strength 0.19
- Andrew J. Gunderson · 2 shared papers, 2020–2021 · strength 0.19
- Eric Tran · 1 shared paper, 2021 · strength 0.10
- Zeljka Jutric · 1 shared paper, 2020 · strength 0.09
- Ronald Wolf · 1 shared paper, 2018 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.